Exxel Pharma Participates in the Virtual Investor 'Top 5 for ‘25' On-Demand Conference
AURORA, CO / ACCESS Newswire Exxel Pharma ('Exxel' or the 'Company'), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today announced it participated in the Virtual Investor 'Top 5 for '25" On-Demand Conference.
As part of the event, Soren Mogelsvang, PhD, President and Chief Executive Officer of Exxel, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to the Company in 2025.
The on-demand video webcast is now accessible for viewing here and on the Investors section of the Company's website ( exxelpharma.com).
About Exxel Pharma
Exxel Pharma is a privately held pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The Company's lead program, EX937, is an oral, first-in-class, patented small molecule designed to specifically and peripherally inhibit the fatty acid amide hydrolase (FAAH) enzyme. Exxel plans to launch a first-in-human Phase 1/1b study of EX937 for the treatment of refractory chronic cough, a large underserved market with no current FDA-approved therapies. In preclinical studies, EX937 demonstrated efficacy in its ability to modulate chronic cough in multiple models. Additionally, EX937 has shown to have a favorable safety profile and is expected to have no CNS side effects by being entirely excluded from the central nervous system and brain. EX937 also has the potential to be utilized across a number of high-value indications, including hyperactive bladder, peripheral neuropathic pain and migraine headaches. Exxel Pharma has a second program (ARN compounds) with the potential to treat Social Anxiety and Autism Spectrum Disorder.
Forward Looking Statements
Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. These statements relate to future events, future expectations, plans and prospects. Although Exxel believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Exxel has attempted to identify forward-looking statements by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including market and other conditions and those discussed under Item 1A. Any forward-looking statements contained in this press release speak only as of its date. Exxel undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events, except as required by law.
Investor Contact
Jenene Thomas
Chief Executive Officer
JTC Team, LLC
T: 908.824.0775
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
25 minutes ago
- The Hill
Mars says M&M's, Starbursts without synthetic dyes coming in 2026
Video above: FDA announces in April 2025 that it will phase out food dyes. (NEXSTAR) — While several other food companies had confirmed they would drop artificial food dyes in response to a mission set forth by Health and Human Services Secretary Robert F. Kennedy Jr. earlier this summer, Mars Wrigley was considered a holdout. That quietly changed late last month. In a late-July statement, which was first reported by Bloomberg on Thursday, Mars Wrigley North America announced it plans to release 'product options' made without artificial dyes in 2026. These options without synthetic dyes will be available only across four of its brands to start, according to the statement: M&M's, Skittles Original, Extra Gum Spearmint, and Starburst Original fruit chews. They'll be available to purchase online throughout the U.S. A spokesperson confirmed to Nexstar that the 'choice products' without artificial dyes will be additions to the current brands. They declined to say whether currently available products will be affected by the dye changes. AT&T reached a $177M settlement over data breaches: Will you get a payment? Mars did not immediately respond to Nexstar's request for additional information, like whether these options will replace others within each brand's portfolio, or if currently available products would be otherwise impacted. 'When we have identified fully effective, scalable solutions across the entire portfolio, we will share additional item commitments and timelines,' the company said in its statement. In April, Food and Drug Administration Commissioner Marty Makary said the agency would move to eliminate several synthetic dyes by the end of next year. That includes Green 3, Red 40, Yellow 5, Yellow 6, Blue 1, and Blue 2. Red 3 was set to be banned in food by 2027 because it caused cancer in laboratory rats; the FDA called for that deadline to move up. The FDA has been relying on companies voluntarily ditching the aforementioned dyes, but does plan to establish a standard and timeline for the food industry to switch to natural alternatives and revoke authorization for dyes not in production. Additionally, the FDA said it would authorize four new natural color additives. Several food manufacturers have already announced plans to ditch synthetic colors. That includes General Mills, Pepsico, ConAgra, Nestle, McCormick, Tyson Foods, Sam's Club, JM Smucker, Hershey, Kraft Heinz, and dozens of companies that make ice cream and frozen dairy desserts. Mars, however, was a holdout as of mid-July. The company now stands to be among the first to have products without artificial dyes available. Artificial dyes are used widely in U.S. foods. In Canada and in Europe — where synthetic colors are required to carry warning labels — manufacturers mostly use natural substitutes. Several states, including California and West Virginia, have passed laws restricting the use of artificial colors in foods. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating they can cause neurobehavioral problems, including hyperactivity and attention issues, in some children. The FDA has maintained that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The FDA currently allows 36 food color additives, including eight synthetic dyes. Removing dyes from the food supply will not address the chief health problems that plague Americans, said Susan Mayne, a Yale University chronic disease expert and former director of the FDA's food center. 'With every one of their announcements, they're focusing in on something that's not going to accomplish what they say it is,' Mayne said of Kennedy's initiatives. 'Most of these food dyes have been in our food supply for 100 years. … So why aren't they driving toward reductions in things that do drive chronic disease rates?'
New York Post
an hour ago
- New York Post
Costco won't sell abortion pills after outcry from religious groups
Costco said it will not offer abortion pills at any of its more than 500 pharmacies nationwide, a move celebrated by religious groups that lobbied against the drug being dispensed by retailers. The Washington state-based wholesaler insisted its decision was based on a lack of customer interest in the medication, Mifepristone, which together with another medicine called misoprostol, is used to end a pregnancy within 10 weeks of gestation. It didn't address whether pressure from conservative organizations influenced the move. 4 A Costco location in the US, one of more than 500 company pharmacies that will not provide Mifepristone. Getty Images A coalition of religious groups including Idaho-based Inspire Investing, the conservative legal organization Alliance Defending Freedom and treasurers and other financial officials from Ohio, Texas, Nevada and Utah had contacted the retailer last year requesting it not carry the drug, according to Bloomberg News. 'It's a very significant win and it's one we hope to build on this coming year,' said Michael Ross, an attorney working with Alliance Defending Freedom's corporate engagement division. Ross indicated the coalition plans to target Walgreens Boots Alliance and CVS next. Both pharmacy chains currently provide mifepristone in states that don't have abortion restrictions. People living in states that have severely limited abortion can obtain the medication by mail from states without such bans. The religious investors sent similar requests last year to Kroger, Walmart and Albertsons alongside Costco, urging them against carrying the medication. Kroger responded that it has never provided abortion pills and continues monitoring regulatory developments. Neither Walmart nor Albertsons currently stocks the medicine. Costco's decision intensifies the ongoing debate about access to the medication. 4 Mifepristone tablets are part of a two-drug regimen to terminate early pregnancies. AP New York City Comptroller Brad Lander had written to various retailers in July last year representing city pension funds, encouraging them to pursue authorization for offering the drug. 'Costco's decision to refuse to dispense mifepristone is disappointing and short-sighted,' a representative from Lander's office told Bloomberg. 'Failure to provide access to proven safe and FDA-approved medication under the guise of 'weak demand' risks isolating customers and undermines the company's credibility.' The Post has sought comment from Costco and Lander. The religious organizations have promised to continue to ramp up pressure. 'We have this momentum,' said Tim Schwarzenberger, who leads corporate engagement at Inspire, which manages the biggest religious exchange-traded fund. 'Now there is a chance to turn to some of the other retailers.' doesn't presently sell the medication, and Schwarzenberger indicated his organization will work to maintain that status. 4 A patient prepares to take mifepristone, which blocks progesterone to end an early-stage pregnancy. AP Amazon didn't provide a response to inquiries. Walgreens declined to comment but referenced information on its website stating: 'The US Supreme Court's ruling on mifepristone access allows Walgreens to continue to dispense mifepristone under the FDA guidelines.' CVS confirmed it distributes mifepristone in certain states where permitted after completing what it called a thorough certification procedure. 'We have a long history of supporting and advancing women's health and we remain focused on meeting their unique health needs. This includes providing access to safe, legal, and evidence-based reproductive health services,' the company stated. The elimination of nationwide abortion protections has resulted in uneven access throughout the US, leading telehealth providers to address some service gaps. Various state legislators have proposed legislation to designate mifepristone as a restricted drug and reduce telehealth availability. According to tracking by the Guttmacher Institute, a nonprofit research organization, lawmakers introduced 32 proposals to prohibit medication abortion and 38 to restrict access during the 2025 legislative period, representing the highest number since the overturn of Roe v. Wade. Data from the Society of Family Planning, an abortion rights organization, shows most abortions in America still occur either at medical facilities or through prescriptions from doctors filled at pharmacies like CVS or Walgreens. A smaller percentage involves prescriptions delivered by mail. 4 Anti-abortion demonstrators rally outside the US Supreme Court in March of last year as debate over medication abortion continues. AP Following increased state-level abortion restrictions, more women have pursued online mifepristone prescriptions for mail delivery. These shipments now represent approximately 25% of American abortions, up from 5 percent before the 2022 Supreme Court decision that ended federal abortion protections. Eight states permitting abortion have enacted protective legislation shielding doctors from prosecution when prescribing mifepristone to patients in states with abortion prohibitions. Ushma Upadhyay, a reproductive sciences professor at the University of California, San Francisco, explained that CVS, Walgreens and similar pharmacies don't provide the medication in states prohibiting abortion, creating difficulties for women seeking the procedure. Telehealth providers can utilize protective laws to ship pills directly to states with restrictions, she noted. This has generated legal disputes. A Texas resident filed a lawsuit in July against a California physician for prescribing abortion medication to his girlfriend. A New York doctor faces criminal charges in Louisiana and a lawsuit from Texas's Attorney General for shipping pills to patients in those states.
Forbes
an hour ago
- Forbes
From Paris To Perth: IHG Celebrates A Milestone Moment- A Million Rooms Worldwide
In 1777, William Bass opened a brewery in the English town of Burton upon Trent—probably never guessing it would, centuries later, have anything to do with hotels. Yet that modest start became the first chapter in a story that would eventually span continents. The business moved beyond beer, picking up hospitality brands along the way, and in 1988 made a pivotal leap with the purchase of Holiday Inn. By 2003, a corporate split created InterContinental Hotels Group, the parent company we know today. Since then, IHG has quietly but steadily expanded into more than 100 countries. And this year? It hit a milestone that even Bass himself might have paused to raise a glass to: the opening of its one-millionth guest room. Malthouses, Bass Old Brewery, Friars' Walk, Burton-on-Trent, Staffordshire, 1960-1974. Artist Eileen Deste. Getty Images 'Reaching one million rooms reflects the deep trust and confidence our guests, owners and investors place in IHG and our brands,' said Elie Maalouf, CEO of IHG Hotels & Resorts. 'But more than that, it's a celebration of our colleagues, who help millions of guests live their best lives every single day… If it matters in life, it happens in our hotels.' Elie Maalouf, chief executive officer of Intercontinental Hotels Group, during a Bloomberg Television interview in London, UK, on Tuesday, June 10, 2025. © 2025 Bloomberg Finance LP In the first half of 2025 alone, IHG opened more than 207 hotels, adding over 31,000 rooms—the biggest six-month growth spurt in the company's history. The milestone wasn't tied to one single property but rather the combined momentum of openings worldwide, from the Kimpton Mas Olas Resort & Spa in Todos Santos, Mexico, to the Holiday Inn Kyoto Gojo in Japan, voco Malta, and Hotel Indigo Hainan Clear Water Bay in China. THe latest opening for IHG is the Kimpton Mas Olas Resort and Spa. IHG Today, IHG sits among the five largest hotel groups in the world, with more than 6,600 properties under its umbrella—sharing the stage with giants like Hilton Worldwide, Jin Jiang International, and H World. Marriott International still leads as the largest hospitality brand in the world with over 1.6 million rooms globally. A big part of IHG's staying power comes from IHG One Rewards, its global loyalty program linking all 20 of its brands. Members rack up points not only for stays, but for dining and partner experiences—redeemable for everything from room upgrades to those 'tell-me-again-how-you-scored-this?' moments. This year, it's offering something close to my heart: a 'grand slam' at one of my favorite events, the US Open Tennis Championships. Guests can get VIP access and even vie for the coveted 'Bed on the Baseline' courtside breakfast. And, with a partnership worth toasting, Moët & Chandon will be pouring its signature Watermelon Slice cocktail in a collectable cup at the IHG Racquet Bar and select New York hotels—a nice symmetry for a company whose beginnings were, quite literally, brewed. In addition, IHG is expanding the celebration through its 'One in a Million Moments' marketing campaign, highlighting memorable IHG rewards members stays and the stories that give those million rooms their meaning. Six Senses Resort, Koh Yao Noi, Phang Nga Bay, Thailand, Asia. Waiter with a candles in the restaurant near the swimming pool called The Hilltop Reserve in front of the sea. Six Senses Yao Noi sets the highest benchmark for island resort living in Asia. (Photo by: Sergi Reboredo/VW PICS/Universal Images Group via Getty Images) Universal Images Group via Getty Images The portfolio covers nearly every travel mood: ultra-luxury escapes such as Six Senses, Regent, and InterContinental; style-forward lifestyle names like Kimpton, Hotel Indigo, voco, Vignette Collection, and HUALUXE; upscale brands including Crowne Plaza, EVEN Hotels, and Iberostar Beachfront Resorts; and the ever-familiar Holiday Inn family. For longer stays, there's Staybridge Suites and Candlewood Suites, and avid hotels and Atwell Suites that cater to more value-driven travelers. Voco Dubai, an IHG Hotel getty With travel demand surging and guest expectations constantly shifting, IHG's one-million-room moment feels less like a finish line and more like a mile marker.
